桡动脉移植物与大隐静脉移植物在冠状动脉旁路移植术中的长期心血管结局关联:系统评价与荟萃分析
该研究对5个国家1997至2009年入组、随访至2019年的随机试验进行患者水平汇总分析,比较冠状动脉旁路移植术中桡动脉与大隐静脉移植物的长期结局。中位随访10年显示,桡动脉组主要复合终点(死亡、心肌梗死或再次血运重建)及死亡或心肌梗死复合终点风险均显著低于大隐静脉组。
要点
- 桡动脉移植物较之大隐静脉可降低长期主要心血管复合终点风险。
- 桡动脉组死亡或心肌梗死复合终点风险亦显著更低。
- 该获益基于中位10年随访的随机对照试验患者水平汇总分析。
核心结论
- 在冠状动脉旁路移植术患者中,使用桡动脉移植物相比大隐静脉移植物与心血管复合结局风险降低相关。
研究设计与样本
- 患者水平汇总分析,比较桡动脉与大隐静脉移植物在成人孤立性冠状动脉旁路移植术中的结局。
- 纳入来自澳大利亚、意大利、塞尔维亚、韩国和英国的5项随机试验,入组时间1997至2009年,随访于2019年完成。
- 共随机分配1036例患者,桡动脉组534例,大隐静脉组502例;942例(90.9%)完成10年随访(桡动脉组510例)。
主要发现
- 中位随访10年(四分位距10-11年),主要复合终点(死亡、心肌梗死或再次血运重建)在桡动脉组与大隐静脉组分别为220例与237例总事件,发生率41 vs 47例/1000患者年,风险比0.73(95%CI 0.61-0.88),P < .001。
- 次要复合终点(死亡或心肌梗死)在桡动脉组与大隐静脉组分别为188例与193例总事件,发生率35 vs 38例/1000患者年,风险比0.77(95%CI 0.63-0.94),P = .01。
关键数值与推荐
- 主要终点为死亡、心肌梗死或再次血运重建的复合终点;次要终点为死亡或心肌梗死的复合终点。
- 桡动脉组平均年龄66.6岁,男性376例(70.4%);大隐静脉组平均年龄67.1岁,男性351例(69.9%)。
临床怎么用
- 在冠状动脉旁路移植术选择移植物时,桡动脉可作为大隐静脉的替代选择以改善长期心血管结局。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE: Observational studies have suggested that the use of radial artery grafts for coronary artery bypass grafting may improve clinical outcomes compared with the use of saphenous vein grafts, but this has not been confirmed in randomized trials. OBJECTIVE: To compare clinical outcomes between patients receiving radial artery vs saphenous vein grafts for coronary artery bypass grafting after long-term follow-up. DESIGN, SETTING, AND PARTICIPANTS: Patient-level pooled analysis comparing radial artery vs saphenous vein graft in adult patients undergoing isolated coronary artery bypass grafting from 5 countries (Australia, Italy, Serbia, South Korea, and the United Kingdom), with enrollment from 1997 to 2009 and follow-up completed in 2019. INTERVENTIONS: Patients were randomized to undergo either radial artery (n = 534) or saphenous vein (n = 502) grafts for coronary artery bypass grafting. MAIN OUTCOMES AND MEASURES: The primary outcome was a composite of death, myocardial infarction, or repeat revascularization and the secondary outcome was a composite of death or myocardial infarction. RESULTS: A total of 1036 patients were randomized (mean age, 66.6 years in the radial artery group vs 67.1 years in the saphenous vein group; 376 [70.4%] men in the radial artery group vs 351 [69.9%] in the saphenous vein group); 942 (90.9%) of the originally randomized patients completed 10 years of follow-up (510 in the radial artery group). At a median (interquartile range) follow-up of 10 (10-11) years, the use of the radial artery, compared with the saphenous vein, in coronary artery bypass grafting was associated with a statistically significant reduction in the incidence of the composite outcome of death, myocardial infarction, or repeat revascularization (220 vs 237 total events; 41 vs 47 events per 1000 patient-years; hazard ratio, 0.73 [95% CI, 0.61-0.88]; P < .001) and of the composite of death or myocardial infarction (188 vs 193 total events; 35 vs 38 events per 1000 patient-years; hazard ratio, 0.77 [95% CI, 0.63-0.94]; P = .01). CONCLUSIONS AND RELEVANCE: In this individual participant data meta-analysis with a median follow-up of 10 years, among patients undergoing coronary artery bypass grafting, the use of the radial artery compared with the saphenous vein was associated with a lower risk of a composite of cardiovascular outcomes.
引用
- Gaudino M, Benedetto U, Fremes S, et al. Association of Radial Artery Graft vs Saphenous Vein Graft With Long-term Cardiovascular Outcomes Among Patients Undergoing Coronary Artery Bypass Grafting: A Systematic Review and Meta-analysis. JAMA. 2020. PMID: 32662861. doi:10.1001/jama.2020.8228
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。